NanoViricides, Inc.
(NYSE Amex Equities : NNVC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.30%198.191.3%$525.15m
GILDGilead Sciences, Inc.
1.52%66.970.9%$355.89m
ALXNAlexion Pharmaceuticals, Inc.
1.16%106.902.0%$331.59m
ILMNIllumina, Inc.
0.67%307.243.5%$318.03m
BIIBBiogen Inc.
2.44%241.361.3%$313.52m
CELGCelgene Corporation
0.57%99.511.3%$296.23m
VRTXVertex Pharmaceuticals Incorporated
1.68%179.101.9%$177.68m
AAgilent Technologies, Inc.
0.68%78.601.6%$177.05m
REGNRegeneron Pharmaceuticals, Inc.
3.13%295.102.6%$171.58m
SRPTSarepta Therapeutics, Inc.
-2.87%82.9114.6%$141.07m
EXASExact Sciences Corporation
0.23%103.6424.1%$139.07m
ACADACADIA Pharmaceuticals Inc.
-0.70%41.3913.9%$124.57m
INCYIncyte Corporation
2.88%80.372.5%$87.65m
ALDRAlder Biopharmaceuticals, Inc.
0.08%18.6810.2%$76.49m
BMRNBioMarin Pharmaceutical Inc.
-0.29%75.784.3%$75.40m

Company Profile

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.